KAREN D. FAIRCHILD
Medical Practice at Lee St, Charlottesville, VA
License number
Virginia 0101236875
Category
Medical Practice
Type
Pediatrics
Address
Address
Lee St, Charlottesville, VA 22908
Phone
(434) 924-0000
Personal information
See more information about KAREN D. FAIRCHILD at radaris.comName
Address
Phone
2525 Wind River Rd, Charlottesville, VA 22901
Organization information
See more information about KAREN D. FAIRCHILD at bizstanding.comUniversity Of Va Health System - Karen D Fairchild MD
1215 Lee St, Charlottesville, VA 22908
Categories:
Pediatrics Physicians & Surgeons
Phone:
(434) 924-5428 (Phone)
Professional information
Karen D Fairchild, Charlottesville VA
Specialties:
Pediatrician
Address:
500 Ray C Hunt Dr, Charlottesville, VA 22903
Hospital Dr, Charlottesville, VA 22908
Hospital Dr, Charlottesville, VA 22908
Education:
Duke University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Sub-certificate in Neonatal-Perinatal Medicine (Pediatrics)
Karen Diane Fairchild, Charlottesville VA
Specialties:
Pediatrics, Neonatal-Perinatal Medicine
Work:
UVA Health Services Foundation
2270 Ivy Rd, Charlottesville, VA 22903
2270 Ivy Rd, Charlottesville, VA 22903
Education:
Duke University(1989)
System, Method And Computer Program Product For The Organism-Specific Diagnosis Of Septicemia In Infants
US Patent:
2013020, Aug 8, 2013
Filed:
Apr 29, 2011
Appl. No.:
13/695243
Inventors:
Karen D. Fairchild - Charlottesville VA, US
Jeffrey Saucerman - Crozet VA, US
Randall J. Moorman - Keswick VA, US
Douglas E. Lake - Charlottesville VA, US
Jeffrey Saucerman - Crozet VA, US
Randall J. Moorman - Keswick VA, US
Douglas E. Lake - Charlottesville VA, US
Assignee:
University of Virginia Patent Foundation, d/b/a Universiy of Virginia Licensing & Ventures Group - Charlottesville VA
International Classification:
C12Q 1/04
US Classification:
435 5, 435 34, 4352871
Abstract:
A method, system, and computer program product for producing an organism specific diagnosis of septicemia in infants is disclosed. The method involves measuring the levels of one or more biomarkers against redefined threshold values and interpreting these levels to arrive at the diagnosis. Other techniques may introduce a preliminary step of identifying higher risk subjects, as well as the integration of such methods into the final diagnostic methodology. One aspect of a technique of this method may involve measuring one more cytokines to detect specific classes of infective organisms, such as Gram-negative bacteria.